Stockscreener 앱 받기
543.32
3.50%
18.36
시간 외 거래:
543.32
전일 마감가:
$524.96
열려 있는:
$525.36
하루 거래량:
3.05M
Relative Volume:
1.27
시가총액:
$205.16B
수익:
$43.21B
순이익/손실:
$6.58B
주가수익비율:
31.45
EPS:
17.2769
순현금흐름:
$6.17B
1주 성능:
+17.03%
1개월 성능:
+12.13%
6개월 성능:
+15.59%
1년 성능:
-9.59%
1일 변동 폭
$525.36
$545.44
1주일 범위
$456.67
$545.44
52주 변동 폭
$385.46
$610.97
써모 피셔 사이언티픽 Stock (TMO) Company Profile
명칭
Thermo Fisher Scientific Inc
전화
(781) 622-1000
주소
168 THIRD AVENUE, WALTHAM, MA
TMO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
써모 피셔 사이언티픽 Stock (TMO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-11 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 개시 | William Blair | Outperform |
| 2025-07-24 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2025-07-11 | 업그레이드 | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | 다운그레이드 | UBS | Buy → Neutral |
| 2025-01-10 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 개시 | Scotiabank | Sector Perform |
| 2024-10-14 | 개시 | Redburn Atlantic | Buy |
| 2024-10-01 | 개시 | Stephens | Overweight |
| 2024-08-28 | 개시 | Wells Fargo | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-03-18 | 재개 | Citigroup | Neutral |
| 2024-01-24 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2024-01-08 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-10-26 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 개시 | Bernstein | Outperform |
| 2023-09-06 | 재개 | Citigroup | Buy |
| 2023-07-19 | 개시 | Raymond James | Outperform |
| 2023-07-19 | 재확인 | Robert W. Baird | Outperform |
| 2023-07-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 재확인 | Barclays | Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Outperform |
| 2022-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 개시 | Credit Suisse | Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 재개 | Barclays | Overweight |
| 2021-10-20 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 개시 | The Benchmark Company | Buy |
| 2021-03-18 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 개시 | Barclays | Overweight |
| 2021-01-08 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-12-02 | 개시 | Goldman | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 개시 | Atlantic Equities | Overweight |
| 2020-09-14 | 개시 | Morgan Stanley | Overweight |
| 2020-08-20 | 재개 | JP Morgan | Overweight |
| 2020-07-15 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 재확인 | Needham | Buy |
| 2020-04-23 | 재확인 | Needham | Buy |
| 2020-01-31 | 재확인 | Needham | Buy |
| 2020-01-22 | 개시 | Credit Suisse | Neutral |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2019-11-15 | 개시 | Stifel | Buy |
| 2019-07-25 | 재확인 | Needham | Buy |
| 2019-07-16 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-05-30 | 개시 | Wolfe Research | Outperform |
| 2019-05-23 | 재확인 | Needham | Strong Buy |
| 2019-04-22 | 재확인 | Needham | Strong Buy |
| 2019-04-16 | 재확인 | BofA/Merrill | Buy |
모두보기
써모 피셔 사이언티픽 주식(TMO)의 최신 뉴스
Jim Cramer on Thermo Fisher: “They Really Got Hurt By COVID” - One News Page
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MSN
Vaxcyte’s Strategic Moves: Impact on PCVX - StocksToTrade
Why Thermo Fisher (TMO) Stock Is Trading Up Today - TradingView
Metagenomics Market Size Booms at 13.55% CAGR, Projects to Climb USD 8.39 Billion by 2034 - GlobeNewswire Inc.
Vector Purification Market Research, Industry Trends & Global Forecasts, 2035, Profiles of Agilent, BIA Separations, Bio-Rad, BioVision, Cytiva, Merck, Sartorius, Takara Bio, Thermo Fisher ScientificResearchAndMarkets.com - Business Wire
KeyBanc maintains Sector Weight rating on Thermo Fisher stock amid mixed segment performance - Investing.com
Thermo Fisher ups the accuracy on elemental analysis - International Mining
Cell and Gene Therapy Manufacturing Services Market Trends & - openPR.com
Where is Thermo Fisher Scientific (TMO) Headed According to Analysts? - MSN
DPIIT inks MoU with Thermo Fisher Scientific to aid 500 biotech startups - Medical Buyer
Thermo Fisher Scientific expands neurodegeneration research capabilities with launch of Olink® Target 48 Neurodegeneration panel - News-Medical
Thermo Fisher Scientific announces pricing of senior notes - Medical Buyer
Will Thermo Fisher Scientific Inc. (TN8) stock return to pre crash levelsJuly 2025 Momentum & Reliable Intraday Trade Alerts - newser.com
Will Thermo Fisher Scientific Inc. stock outperform growth indexesQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Q&A: Thermo Fisher’s Luke Wilson on hitting 100% dose delivery with patient-centric supply - drugdiscoverytrends.com
Vaxcyte strikes up to $1B deal for fill-finish space at Thermo Fisher's N.C. production facility - Fierce Pharma
November 14th Options Now Available For Thermo Fisher Scientific (TMO) - Nasdaq
Hans Scientific invests $2B in US to avoid tariffs; Thermo Fisher inks up to $1B contract - Endpoints News
Vaxcyte teams up with Thermo Fisher to ensure future vaccine production - MSN
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday October 22 2025 - MarketScreener
Barclays Adjusts Price Target on Thermo Fisher Scientific to $585 From $550, Maintains Overweight Rating - MarketScreener
Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub - BioSpace
Bernstein Reaffirms Outperform Rating on Thermo Fisher (TMO) After Investor Roadshow - Yahoo Finance
DPIIT, Thermo Fisher Scientific tie up to boost India’s biotech startup ecosystem - Social News XYZ
Thermo Fisher Scientific gibt Forschungskooperation mit AstraZeneca BioVentureHub bekannt - The Joplin Globe
Thermo Fisher Scientific annonce un partenariat de recherche et développement avec l'AstraZeneca BioVentureHub - Enidnews.com
Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism - FinancialContent
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher’s Strategic Moves: Surging Ahead? - StocksToTrade
Thermo Fisher (TMO) Stock Trades Up, Here Is Why - Yahoo Finance
Thermo Fisher Scientific Hits Day High with 4.48% Surge in Stock Price - Markets Mojo
Thermo Fisher Scientific Showcases the Thermo Fisher Connect Platform at Lab of the Future Europe - MarketScreener
Thermo Fisher Scientific (TMO) Rises After Completing $2.5 Billi - GuruFocus
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 22, 2025 - PharmiWeb.com
Thermo Fisher Scientific (TMO) Rises Amid Positive Market Sentim - GuruFocus
Bernstein reiterates Outperform rating on Thermo Fisher stock By Investing.com - Investing.com UK
GCC Liquid Biopsy Market Forecast and Company Analysis - GlobeNewswire
Thermo Fisher Scientific Prices $2.5 Billion Worth of Debt Offerings - MarketScreener
Product Management Specialist II Job at Thermo Fisher Scientific- Apply Now - BioTecNika
Thermo Fisher Scientific (TMO) Launches $2.5 Billion Senior Notes Offering - GuruFocus
Thermo Fisher Scientific prices $2.5B senior notes - MSN
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MSN
Thermo Fisher Scientific Prices Offering of USD-Denominated Senior Notes - PharmiWeb.com
Thermo Fisher prices $2.5 billion notes offering across four maturities By Investing.com - Investing.com Australia
Thermo Fisher Scientific Prices $2.5 Bln Offering Of Notes - Nasdaq
Thermo Fisher launches Chromeleon 7.4, an enterprise chromatography–MS data system with 21 CFR Part 11 controls - R&D World
Thermo Fisher prices $2.5 billion notes offering across four maturities - Investing.com India
Thermo Fisher Scientific says co prices offering of USD-denominated senior notes - MarketScreener
Thermo Fisher Scientific files for four-part senior notes offering of upto $2.5 billionSEC filing - MarketScreener
Thermo Fisher Kicks Off Four-Part High-Grade Bond Sale - Bloomberg.com
써모 피셔 사이언티픽 (TMO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.22%
0.42%
자본화:
|
볼륨(24시간):